CorMedix (CRMD) Free Cash Flow (2010 - 2025)

CorMedix has disclosed Free Cash Flow across 15 years of filings, most recently posting $92.7 million for Q4 2025.

• Free Cash Flow for Q4 2025 came in at $92.7 million, up 1748.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $172.8 million (up 440.59% YoY), and the FY2025 annual result was $172.8 million, up 440.59% from the prior year.
• Free Cash Flow came in at $92.7 million for Q4 2025 at CorMedix, up from $30.4 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $92.7 million in Q4 2025 to a low of -$17.4 million in Q1 2024.
• The 5-year median for Free Cash Flow is -$6.4 million (2021), against an average of $1.8 million.
• Across the five-year window, Free Cash Flow plunged 308.37% in 2021 and jumped 1748.72% in 2025, its largest moves.
• CorMedix's Free Cash Flow stood at -$6.5 million in 2021, then gained by 3.3% to -$6.3 million in 2022, then sank by 75.72% to -$11.0 million in 2023, then jumped by 49.06% to -$5.6 million in 2024, then surged by 1748.72% to $92.7 million in 2025.
• The last three Free Cash Flow figures came in at $92.7 million (Q4 2025), $30.4 million (Q3 2025), and $30.0 million (Q2 2025), per Business Quant data.